Aldo Germani

Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors

M. Cutrone, R. Tenconi, L. Chessa, 2015, PloS one.

Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38

P. Ditonno, M. Battaglia, E. Maiorano, 2015, Autophagy.

Targeted therapy against chemoresistant colorectal cancers: Inhibition of p38α modulates the effect of cisplatin in vitro and in vivo through the tumor suppressor FoxO3A.

G. Ingravallo, C. Simone, G. Canettieri, 2014, Cancer letters.

Blocking p38/ERK crosstalk affects colorectal cancer growth by inducing apoptosis in vitro and in preclinical mouse models.

Fulvio Chiacchiera, Nicoletta Resta, M. Moyer, 2012, Cancer letters.

A SMYD3 Small‐Molecule Inhibitor Impairing Cancer Cell Growth

Greta Varchi, Alberto Del Rio, Carlo Bertucci, 2015, Journal of cellular physiology.

401 Loss of LKB1/STK11 expression is an early event in prostate cancer development and predicts therapeutic response to p38α inhibitor

P. Ditonno, M. Battaglia, C. Simone, 2015 .

Blocking p38/ERK crosstalk affects colorectal cancer growth by inducing apoptosis in vitro and in preclinical mouse models.

M. Moyer, C. Simone, M. Simonatto, 2012, Cancer letters.